{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T22:05:40Z","timestamp":1744063540754},"reference-count":38,"publisher":"Elsevier BV","issue":"19-20","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.cca.2010.05.041","type":"journal-article","created":{"date-parts":[[2010,6,5]],"date-time":"2010-06-05T08:20:21Z","timestamp":1275726021000},"page":"1461-1465","source":"Crossref","is-referenced-by-count":18,"title":["The prevalence and diagnostic value of perinuclear antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibodies in patients with inflammatory bowel disease in mainland China"],"prefix":"10.1016","volume":"411","author":[{"given":"Feng","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fubing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umid Kumar","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Honglin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianyan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhitao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2010.05.041_bib1","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMra020831","article-title":"Inflammatory bowel disease","volume":"347","author":"Podolsky","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cca.2010.05.041_bib2","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1572-0241.2006.00468.x","article-title":"Utility of serological markers in predicting the early occurrence of complications and surgery in pediatric Crohn's disease patients","volume":"101","author":"Amre","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cca.2010.05.041_bib3","first-page":"359","article-title":"Established and emerging biological activity markers of inflammatory bowel disease","volume":"95","author":"Nielsen","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cca.2010.05.041_bib4","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/00054725-200309000-00003","article-title":"Association of perinuclear antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibodies with Vienna classification subtypes of Crohn's disease","volume":"9","author":"Klebl","year":"2003","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cca.2010.05.041_bib5","first-page":"449","article-title":"Anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic autoantibodies in Greek patients with inflammatory bowel disease","volume":"96","author":"Koutroubakis","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cca.2010.05.041_bib6","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1111\/j.1572-0241.2006.00840.x","article-title":"Diagnostic precision of anti-Saccharomyces cerevisiae antibodies and perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease","volume":"101","author":"Reese","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cca.2010.05.041_bib7","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1053\/gast.1996.v110.pm8964407","article-title":"Perinuclear anti-neutrophil cytoplasmic antibodies in patients with Crohn's disease define a clinical subgroup","volume":"110","author":"Vasiliauskas","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cca.2010.05.041_bib8","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1097\/01.mib.0000235833.47423.d7","article-title":"Antibodies to I2 predict clinical response to fecal diversion in Crohn's disease","volume":"12","author":"Spivak","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cca.2010.05.041_bib9","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1155\/2001\/605470","article-title":"Development of an assay for antibodies to Saccharomyces cerevisiae: Easy, cheap and specific for Crohn's disease","volume":"15","author":"Bernstein","year":"2001","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.cca.2010.05.041_bib10","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1136\/gut.46.1.58","article-title":"Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn's disease","volume":"46","author":"Sutton","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.cca.2010.05.041_bib11","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1111\/j.1572-0241.2004.40486.x","article-title":"A prospective comparative study of ASCA and pANCA in Chinese and Caucasian IBD patients","volume":"99","author":"Lawrance","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cca.2010.05.041_bib12","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3109\/00365528909091339","article-title":"Classification of inflammatory bowel disease","volume":"24","author":"Lennard-Jones","year":"1989","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cca.2010.05.041_bib13","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1136\/bmj.2.4947.1041","article-title":"Cortisone in ulcerative colitis; final report on a therapeutic trial","volume":"29","author":"Truelove","year":"1955","journal-title":"Br Med J"},{"key":"10.1016\/j.cca.2010.05.041_bib14","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0016-5085(76)80163-1","article-title":"Development of a Crohn's disease activity index","volume":"70","author":"Best","year":"1976","journal-title":"Gastroenterology"},{"issue":"Suppl A","key":"10.1016\/j.cca.2010.05.041_bib15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1155\/2005\/269076","article-title":"Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology","volume":"19","author":"Silverberg","year":"2005","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.cca.2010.05.041_bib16","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/00054725-200309000-00007","article-title":"Indeterminate colitis","volume":"9","author":"Geboes","year":"2003","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cca.2010.05.041_bib17","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.1572-0241.2001.03618.x","article-title":"Clinical utility of serodiagnostic testing in suspected pediatric inflammatory bowel disease","volume":"96","author":"Dubinsky","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cca.2010.05.041_bib18","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1007\/s10350-004-6361-3","article-title":"Diagnostic role of anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic antibodies in patients with inflammatory bowel disease","volume":"45","author":"Kim","year":"2002","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.cca.2010.05.041_bib19","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1097\/01.mcg.0000173853.78042.2d","article-title":"The diagnostic accuracy of serologic markers in children with IBD: the West Virginia experience","volume":"39","author":"Elitsur","year":"2005","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.cca.2010.05.041_bib20","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.dld.2003.07.001","article-title":"Diagnostic role and clinical correlates of anti-Saccharomyces cerevisiae antibodies (ASCA) and anti-neutrophil cytoplasmic antibodies (p-ANCA) in Italian patients with inflammatory bowel diseases","volume":"35","author":"Saibeni","year":"2003","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cca.2010.05.041_bib21","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1053\/j.gastro.2007.08.032","article-title":"The genetics of inflammatory bowel disease","volume":"133","author":"Cho","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cca.2010.05.041_bib22","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1155\/2008\/974540","article-title":"Perinuclear antineutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies as serological markers are not specific in the identification of Crohn's disease and ulcerative colitis","volume":"22","author":"Anand","year":"2008","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.cca.2010.05.041_bib23","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/j.1572-0241.1999.01081.x","article-title":"Antineutrophil cytoplasmic antibodies in Japanese patients with inflammatory bowel disease: prevalence and recognition of putative antigens","volume":"94","author":"Sugi","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cca.2010.05.041_bib24","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/ibd.20047","article-title":"The prevalence of genetic and serologic markers in an unselected European population-based cohort of IBD patients","volume":"13","author":"Riis","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cca.2010.05.041_bib25","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1023\/A:1019926121972","article-title":"Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies for inflammatory bowel disease: high prevalence in patients with celiac disease","volume":"22","author":"Damoiseaux","year":"2002","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.cca.2010.05.041_bib26","first-page":"1443","article-title":"pANCA and ASCA in the diagnosis of different subtypes of inflammatory bowel disease","volume":"54","author":"Mokrowiecka","year":"2007","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.cca.2010.05.041_bib27","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1111\/j.1572-0241.2004.40417.x","article-title":"Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2\/CARD15 genotype","volume":"99","author":"Arnott","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cca.2010.05.041_bib28","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1111\/j.1572-0241.2004.40369.x","article-title":"Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype","volume":"99","author":"Zholudev","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cca.2010.05.041_bib29","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1572-0241.2001.03613.x","article-title":"Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease","volume":"96","author":"Peeters","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cca.2010.05.041_bib30","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1136\/gut.42.6.788","article-title":"Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role","volume":"42","author":"Quinton","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.cca.2010.05.041_bib31","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1080\/003655201750065960","article-title":"Anti-Saccharomyces cerevisiae antibodies in inflammatory bowel disease: a family study","volume":"36","author":"Seibold","year":"2001","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cca.2010.05.041_bib32","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1136\/gut.2005.065557","article-title":"Genetic basis for increased intestinal permeability in families with Crohn's disease: role of CARD15 3020insC mutation?","volume":"55","author":"Buhner","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.cca.2010.05.041_bib33","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/00054725-200108000-00003","article-title":"Evaluation of serologic disease markers in a population-based cohort of patients with ulcerative colitis and Crohn's disease","volume":"7","author":"Sandborn","year":"2001","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cca.2010.05.041_bib34","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1136\/gut.2004.060228","article-title":"Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease","volume":"54","author":"Israeli","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.cca.2010.05.041_bib35","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1159\/000109928","article-title":"Diagnostic value of serological assays in pediatric inflammatory bowel disorders","volume":"75","author":"Mainardi","year":"2007","journal-title":"Digestion"},{"key":"10.1016\/j.cca.2010.05.041_bib36","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/01.MIB.0000201098.26450.ae","article-title":"Retrospective survey of 452 patients with inflammatory bowel disease in Wuhan city, central China","volume":"12","author":"Jiang","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cca.2010.05.041_bib37","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1373\/clinchem.2005.058560","article-title":"Serologic markers in inflammatory bowel disease","volume":"52","author":"Bossuyt","year":"2006","journal-title":"Clin Chem"},{"key":"10.1016\/j.cca.2010.05.041_bib38","doi-asserted-by":"crossref","first-page":"667","DOI":"10.7326\/0003-4819-120-8-199404150-00008","article-title":"Guidelines for meta-analyses evaluating diagnostic tests","volume":"120","author":"Irwig","year":"1994","journal-title":"Ann Intern Med"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898110003748?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898110003748?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T21:20:29Z","timestamp":1559164829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898110003748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":38,"journal-issue":{"issue":"19-20","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0009898110003748"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2010.05.041","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}